BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26541461)

  • 1. Redefining the BH3 Death Domain as a 'Short Linear Motif'.
    Aouacheria A; Combet C; Tompa P; Hardwick JM
    Trends Biochem Sci; 2015 Dec; 40(12):736-748. PubMed ID: 26541461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folding and binding pathways of BH3-only proteins are encoded within their intrinsically disordered sequence, not templated by partner proteins.
    Crabtree MD; Mendonça CATF; Bubb QR; Clarke J
    J Biol Chem; 2018 Jun; 293(25):9718-9723. PubMed ID: 29716994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR determination that an extended BH3 motif of pro-apoptotic BID is specifically bound to BCL-XL.
    Ji H; Shekhtman A; Ghose R; McDonnell JM; Cowburn D
    Magn Reson Chem; 2006 Jul; 44 Spec No(Spec No):S101-7. PubMed ID: 16826547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BID: a novel BH3 domain-only death agonist.
    Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
    Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bcl-2 family: structures, interactions and targets for drug discovery.
    Kvansakul M; Hinds MG
    Apoptosis; 2015 Feb; 20(2):136-50. PubMed ID: 25398535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of BH3 Sequence Specificity for the Disruption of Bcl-xL/cBid Complexes in Membranes.
    Das KK; Shalaby R; García-Sáez AJ
    ACS Chem Biol; 2017 Apr; 12(4):989-1000. PubMed ID: 28170214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
    Denisov AY; Chen G; Sprules T; Moldoveanu T; Beauparlant P; Gehring K
    Biochemistry; 2006 Feb; 45(7):2250-6. PubMed ID: 16475813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural biology of BH3-only proteins.
    Kvansakul M; Hinds MG
    Methods Enzymol; 2014; 544():49-74. PubMed ID: 24974286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Details of BH3 Motifs and BH3-Mediated Interactions: an Updated Perspective.
    Sora V; Papaleo E
    Front Mol Biosci; 2022; 9():864874. PubMed ID: 35685242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria.
    Zimmermann AK; Loucks FA; Schroeder EK; Bouchard RJ; Tyler KL; Linseman DA
    J Biol Chem; 2007 Oct; 282(40):29296-304. PubMed ID: 17690097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural plasticity underpins promiscuous binding of the prosurvival protein A1.
    Smits C; Czabotar PE; Hinds MG; Day CL
    Structure; 2008 May; 16(5):818-29. PubMed ID: 18462686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes.
    Terrones O; Etxebarria A; Landajuela A; Landeta O; Antonsson B; Basañez G
    J Biol Chem; 2008 Mar; 283(12):7790-803. PubMed ID: 18195012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Approaches for Predicting Disordered Protein Motifs.
    Bhowmick P; Guharoy M; Tompa P
    Adv Exp Med Biol; 2015; 870():291-318. PubMed ID: 26387106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death.
    Yin XM
    Gene; 2006 Mar; 369():7-19. PubMed ID: 16446060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bid: a Bax-like BH3 protein.
    Billen LP; Shamas-Din A; Andrews DW
    Oncogene; 2008 Dec; 27 Suppl 1():S93-104. PubMed ID: 19641510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737.
    Stauffer SR
    Curr Top Med Chem; 2007; 7(10):961-5. PubMed ID: 17508927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L).
    Maiuri MC; Criollo A; Tasdemir E; Vicencio JM; Tajeddine N; Hickman JA; Geneste O; Kroemer G
    Autophagy; 2007; 3(4):374-6. PubMed ID: 17438366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Bcl-2 family binding models rooted in experiment or structure.
    DeBartolo J; Dutta S; Reich L; Keating AE
    J Mol Biol; 2012 Sep; 422(1):124-44. PubMed ID: 22617328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.